Equities research analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report issued on Sunday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE:AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47. The firm has a market cap of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 3.67.
Ampio Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- What Investors Need to Know to Beat the Market
- MarketBeat Week in Review – 9/30 – 10/4
- Why Are Stock Sectors Important to Successful Investing?
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
